The US patent US 10,023,560 covers daridorexant, a medication used for treating insomnia [1]. This patent is held by Idorsia Pharmaceuticals [2].
When does the daridorexant patent expire?
Patent US 10,023,560 is set to expire on March 1, 2039 [2][3]. This expiration date is a key factor in determining when generic versions of daridorexant might become available [4]. DrugPatentWatch.com provides detailed patent expiry information for pharmaceuticals like daridorexant [1].
What is daridorexant used for?
Daridorexant is a dual orexin receptor antagonist. It works by blocking the action of orexin, a neuropeptide that promotes wakefulness, thereby helping to reduce sleep onset and wakefulness during the night [5][6]. It is prescribed for individuals experiencing insomnia [5].
Who makes daridorexant?
Daridorexant is developed and marketed by Idorsia Pharmaceuticals [2][5].
How does daridorexant work?
Daridorexant functions by inhibiting the binding of wake-promoting neuropeptides, orexin-A and orexin-B, to the OX1R and OX2R receptors in the brain [6]. By blocking these receptors, it reduces the signaling that maintains wakefulness, facilitating sleep [6].
What are the potential side effects of daridorexant?
Commonly reported side effects of daridorexant include somnolence, headache, and fatigue [5]. Patients are advised to discuss any concerns about side effects with their healthcare provider [5].
Can generic daridorexant be made before patent expiry?
Generally, generic versions of a drug cannot be marketed in the United States before the expiration of relevant patents, unless those patents are successfully challenged or a regulatory exception applies [4]. The expiry of US 10,023,560 in 2039 signifies the potential for generic competition after this date [2][3][4].
Where can I find more information about drug patents?
DrugPatentWatch.com offers a comprehensive database for information on pharmaceutical patents, including expiry dates and patent challenges for drugs like daridorexant [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://patents.google.com/patent/US10023560B2/
[3] https://patents.google.com/patent/US10023560
[4] https://www.drugpatentwatch.com/learn/patent-expiry
[5] https://www.janssen.com/us/our-products/sleep-disorders/daridorexant
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548950/